Johnson & Johnson (JNJ)
Pre-market: 05:49AM EDT
| Previous close | 172.18 |
| Open | 172.54 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1200 |
| Day's range | 171.84 - 172.98 |
| 52-week range | 133.65 - 173.65 |
| Volume | 5,346,742 |
| Avg. volume | 6,560,257 |
| Market cap | 453.471B |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 25.89 |
| EPS (TTM) | 6.65 |
| Earnings date | 19 Oct 2021 |
| Forward dividend & yield | 4.24 (2.46%) |
| Ex-dividend date | 23 Aug 2021 |
| 1y target est | 187.39 |
- Motley Fool
How Novavax Could Shake Up the COVID Vaccine Market
Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) share the U.S. COVID-19 vaccine market right now. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss how Novavax (NASDAQ: NVAX) could potentially shake up the COVID vaccine market.
- Motley Fool
3 Top Robinhood Stocks to Buy in August Instead of Dogecoin
In fact, the three companies I'll discuss today are in the top 50 of investing app Robinhood's most popular user holdings. Johnson & Johnson (NYSE: JNJ) will never again grow as quickly as Dogecoin, but it won't collapse as suddenly, either. The key reason that Johnson & Johnson is better than Dogecoin is that the company actually makes things -- specifically, a plethora of consumer healthcare and pharmaceutical products that people need on a daily basis to survive.
- Motley Fool
Will Moderna’s Tenure on the S&P 500 Index Be Short-Lived?
Moderna (NASDAQ: MRNA) is now officially a member of the S&P 500. In this Motley Fool Live video recorded on July 21, 2021, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss whether or not Moderna's tenure on the S&P 500 index will be short-lived. Let's go over to Moderna, which is now officially, I think today, a member of the S&P 500 Index.
